China NMPA Approves Phase II Clinical Trial of ASC40 for the Treatment of Patients with Acne ...Middle East

PR Newswire - News
HANGZHOU and SHAOXING, China, Aug. 8, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that China National Medical Products Administration (NMPA) has approved the Phase II clinical trial application of ASC40 for the treatment of patients with moderate to severe...

Hence then, the article about china nmpa approves phase ii clinical trial of asc40 for the treatment of patients with acne was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( China NMPA Approves Phase II Clinical Trial of ASC40 for the Treatment of Patients with Acne )

Apple Storegoogle play

Last updated :

Also on site :